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Background: Collateral circulation in ischemic stroke patients plays an important role in
infarct evolution und assessing patients’ eligibility for endovascular treatment. By means
of dynamic susceptibility contrast MRI, we aimed to investigate the effects of reperfusion,
recanalization, and collateral flow on clinical and imaging outcomes after stroke.
Methods: Retrospective analysis of 184 patients enrolled into the prospective
observational 1000Plus study (clinicaltrials.org NCT00715533). Inclusion criteria were
vessel occlusion on baseline MR-angiography, imaging within 24 h after stroke onset
and follow-up perfusion imaging. Baseline Higashida score using subtracted dynamic
MR perfusion source images was used to quantify collateral flow. The influence of
these variables, and their interaction with vessel recanalization, on clinical and imaging
outcomes was assessed using robust linear regression.
Results: Ninety-eight patients (53.3%) showed vessel recanalization. Higashida score
(p = 0.002), and recanalization (p = 0.0004) were independently associated with
reperfusion. However, we found no evidence that the association between Higashida
score and reperfusion relied on recanalization status (p = 0.2). NIHSS on admission
(p < 0.0001) and recanalization (p = 0.001) were independently associated with
long-term outcome at 3 months, however, Higashida score (p = 0.228) was not.
Conclusion: Higashida score and recanalization were independently associated with
reperfusion, but the association between recanalization and reperfusion was similar
regardless of collateral flow quality. Recanalization was associated with long-term
outcome. DSC-based measures of collateral flow were not associated with long-term
outcome, possibly due to the complex dynamic nature of collateral recruitment, timing
of imaging and the employed post-processing.
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INTRODUCTION
In stroke patients with occlusions of large, proximal branches
of the arteries supplying the brain, vessel recanalization is the
major factor associated with good clinical outcomes and less
infarct growth. Although factors such as the quality of collateral
flow also influence outcomes (1–3), recanalization is regarded as
being the most important predictor of good outcomes in these
patients (4, 5).
However, depending on how they are defined, large vessel
occlusions occur in under a third of all patients with acute
ischemic stroke (6–8). In the remaining patients, factors besides
vessel recanalization potentially play a larger role in determining
stroke outcome. These include the quality of collateral flow,
which is important for maintaining perfusion in critically
hypoperfused brain tissue (9). Tissue reperfusion, which often
but not inevitably follows vessel recanalization (10–13), also
affects stroke outcome beyond the effect of recanalization (12,
14). Reperfusion itself is influenced by the patency of the vessel
feeding the affected area, the cerebral perfusion pressure, and the
blood’s flow properties (14).
It is clear that these interrelated phenomena—collateral
flow, vessel recanalization, and tissue reperfusion—are essential
factors contributing to the pathophysiology and progression
(and thus outcome) of stroke. However, in clinical practice,
these phenomena are often not measured directly. Instead,
they are operationalized using measurements that are as non-
invasive and convenient as possible. What is unclear is how these
operationalized measurements are related to stroke outcome, as
evidence regarding this has thus far been mixed (10, 15, 16).
The aim of this study was thus to investigate the relationship
between MRI-based operationalized measurements of collateral
flow, tissue reperfusion, and vessel recanalization on clinical and
imaging outcomes. Importantly, this study aims to determine
how these phenomena interact in a population where this
interaction is likelymost relevant—acute ischemic stroke patients
with a wide range of vessel pathologies and infarct distributions.
MATERIALS AND METHODS
Patients
This study is a retrospective analysis of 184 patients enrolled into
the prospective observational 1000Plus study (clinicaltrials.org
NCT00715533) at the Charité-Universitätsmedizin Berlin from
September 2008 to June 2013. Inclusion criteria were MR-
angiographic proven vessel occlusion on day of admission, MR
imaging within 24 h after stroke onset (baseline) and perfusion
imaging (PI) 24 h later (follow-up). The study design was
approved by the institutional review board of the Charité-
Universitätsmedizin, Berlin (EA4/026/08). Written informed
consent was obtained from all patients.
Imaging
MRI examinations were performed on a three Tesla MRI scanner
(Tim Trio; Siemens AG, Erlangen, Germany) with a standard
stroke imaging protocol described in detail (17).
Perfusion imaging (PI) data was analyzed using block-
circulant singular value decomposition deconvolution and an
arterial input function from the contralateral middle cerebral
artery (18) (Stroketool version 2.8, ©Digital Image Solutions-
HJ Wittsack).
Reperfusion was defined as the change in Tmax > 6 s
volume between baseline and follow-up as a percentage of the
baseline Tmax volume. Collateral flow at baseline was assessed
using the Higashida score (19) using subtracted dynamic MR
perfusion source images (sMRP-SI) (20). The Higashida scale is
a modification of the American Society of Interventional and
Therapeutic Neuroradiology/Society of Radiology (ASITN/SIR)
Collateral Flow Grading System and uses five grades to describe
collateral flow of the ischemic region (19). Higashida scores
were dichotomized into good (3, 4) and poor (0–2) (21). Two
experienced radiologists (IG, KV, consensus reading) performed
the scoring.
Perfusion volume was obtained using an in-house automated,
user-independent delineation algorithm (22). From these
volumes, the hypoperfusion intensity ratio (HIR) was also
calculated for each patient as a different DSC-based measure
of collateral flow (23). HIR was defined as the ratio between
the Tmax > 8 s volume and Tmax > 2 s volume, as originally
described (16, 23).
Vessel recanalization was classified according to the TIMI
score (24) and binarized into present (TIMI = 2 or 3) or absent
(TIMI = 0 or 1), as applied in previous studies (4, 12, 22, 25).
Infarct growth was defined as the difference in baseline diffusion
weighted imaging and fluid attenuated inversion recovery lesion
volume 5 days following stroke onset.
Statistical Analysis
Statistical analysis was performed using R Studio and R packages
“Imrob” from “robustbase” package (20), and robust GLM (26).
We performed a sample size calculation and found that the
minimum sample size needed to detect a minimum effect size
(Cohen’s f2) of 0.1 (27) at a significance level of 0.05 and a power
of 0.8 with 8 degrees of freedom (including main effects and
interactions) was 158 [R package pwr (28)].
A robust generalized linear model was used to investigate the
association between different clinical and imaging variables and
reperfusion, long-term clinical outcome (modified Rankin Scale
= mRS at day 90), and infarct growth. To account for potential
differences in the factors associated with reperfusion, clinical
outcome, and imaging outcome between patients with strokes
in different locations, we included stroke location (anterior vs.
posterior circulation) as a covariate in all models.
An alpha level p < 0.05 was considered as significant.
RESULTS
The data and analysis scripts used in this study are available
at https://www.github.com/ahmedaak/1000plus_collaterals_
perfusion.
We included 184 patients into our study. Patient
characteristics are given in Table 1.
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TABLE 1 | Patient Characteristics.
Variable Value
















NIHSS on admission 6 (3–13)
NIHSS at discharge† 2 (0–6)
mRS at day 90‡ 2 (1–4)
DWI volume at baseline (mL) 5.4 (1.0–17.8)
DWI volume at follow-up (mL) 12.4 (3.0–39.1)
FLAIR volume at day 5 (mL)§ 17.9 (5.9–54.8)
Tmax >6 s volume at baseline (mL) 27.0 (11.0–67.2)
Tmax >6 s volume at follow-up (mL) 7.0 (1.0–27.6)












HIR at baseline 0.2 (0.1–0.4)
HIR at follow-up 0.1 (0.01–0.3)
All values are shown as median and interquartile range (IQR) except for categorical
variables, which are shown as percentages. Data is shown for the full sample of 184
patients, except where data was missing (
†
N = 183, ‡N = 148, §N = 140). NIHSS,
National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; DWI, diffusion
weighted imaging; FLAIR, fluid attenuated inversion recovery; TIMI score, thrombolysis in
myocardial infarction score; HIR, hypoperfusion intensity ratio.
Eighty patients (43.5%) received intravenous tissue
plasminogen activator. None received mechanical
thrombectomy. The distribution of vessel occlusions in
the cohort is shown on Supplementary Figure 1. Eighty-
six patients (46.7%) showed persistent vessel occlusion
on follow-up measurements, while ninety-eight (53.3%)
showed recanalization.
We ran several multiple linear regression models to test
the association between reperfusion and various clinical and
imaging variables. The results of the models incorporating
Higashida score as a measure of collateral flow are reported here
and in Supplementary Tables 1–3. The results of the models
incorporating HIR and reperfusion are only shown in the
Supplementary Material.
In the first model, the Higashida score and recanalization
were significant predictors of reperfusion (Figure 1A,
Supplementary Table 1). To investigate whether the effect
of recanalization on reperfusion was different depending on
collateral flow quality, we included the interaction between
Higashida score with recanalization status in the models.
There was no significant interaction between these variables
(Figure 1B, Supplementary Table 1).
Clinical Outcome
Variables associated with clinical outcome are shown in
Supplementary Table 2. In a univariate analysis, we found a
significant association between mRS day 90 and Higashida score
(b = 0.53, t = 3.06, p = 0.003), but not with reperfusion (b =
−0.001, t =−1.55, p= 0.124). However, neither Higashida score
(b = 0.26, t = 1.21, p = 0.228) nor reperfusion (b = −0.017,
t = −0.14, p = 0.891) was independently associated with mRS
day 90, when NIHSS on admission, iv-tPA, recanalization, and
anterior vs. posterior circulation were accounted for (Figure 2A,
Supplementary Table 2). There were no significant interactions
between collateral flow and recanalization on mRS day 90
(Figure 2B, Supplementary Table 2).
Infarct Growth
Higashida score (b = 0.19, t =2.28, p = 0.025), as well as
stroke severity (NIHSS) on admission (b = 0.17, t = 4.79,
p = 0.0001), was associated with infarct growth (Figure 3A,
Supplementary Table 3). There were no significant interactions
between collateral flow and recanalization on infarct growth
(Figure 3B, Supplementary Table 3).
DISCUSSION
In stroke, imaging plays an important role in selecting patients
most likely to benefit from specific treatments, extending the use
of established treatments to previously excluded subpopulations,
and monitoring the effects of novel treatments (29). In this
study, we investigated the association between several MRI-
derived markers and stroke outcome. The results of this study
potentially help us understand the value of these operationalized
measurements in a cohort of stroke patients that is representative
of patients encountered in a clinical setting.
We found that both good collateral flow (assessed using
subtracted dynamic MR perfusion source images) and
recanalization were independently associated with reperfusion.
However, the effect of recanalization on reperfusion was similar
in both patients with and without good collateral flow. Thus, far,
few studies have investigated the interaction between MR-based
measures of reperfusion, recanalization, and collateral flow.
Studying 33 patients within 6 h of stroke onset, Makris et al.
found that patients without vessel recanalization but with
good collateral flow (Higashida score 3–4) had higher degrees
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FIGURE 1 | (A) Association between several variables and reperfusion. The dots indicate the beta coefficients derived from a robust multiple linear regression. Bars
indicate the 95% confidence intervals (CI) of the estimates. Independent variables shown in red have statistically significant coefficients (p < 0.05). (B) Plot showing
the predicted reperfusion values for recanalizers and non-recanalizers with good and poor Higashida scores. The plot shows that vessel recanalization and good
collateral flow are associated with more reperfusion. The association between recanalization and reperfusion is similar across patients, whether or not they have good
collateral flow.
FIGURE 2 | (A) Association between several variables and clinical outcome (mRS day 90). The dots indicate the beta coefficients derived from a robust multiple linear
regression. Bars indicate the 95% confidence intervals (CI) of the estimates. Independent variables shown in red have statistically significant coefficients (p < 0.05).
(B) Plot showing the predicted mRS day 90 values for recanalizers and non-recanalizers with good and poor Higashida scores. The plot shows that vessel
recanalization is associated with lower mRS at day 90, but there is no significant association between Higashida score and mRS at day 90. In addition, the association
between recanalization and mRS at day 90 is similar across patients, whether or not they have good collateral flow.
of reperfusion than patients with poor collaterals (10). Our
study confirms this finding (Figure 1B), despite the fact that
our study design differed from that of Makris et al., with the
first examination taking place within 24 h after stroke onset
and follow-up measurements 24 h later. Our patient sample
was also larger and more heterogeneous (including posterior
circulation strokes, as well as proximal and distal occlusions)
and our analysis accounted for potential confounding variables
such as NIHSS on admission and treatment with intravenous
thrombolysis. Extending the findings of Makris et al., we show
that the observation that good collateral flow is associated
with more reperfusion also applies to patients with vessel
recanalization (Figure 1B).
Poor collateral flow was also independently associated with
more infarct growth, and this relationship was similar in patients
with and without vessel recanalization. The former finding is in
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FIGURE 3 | (A) Association between several variables and infarct growth. The dots indicate the beta coefficients derived from a robust multiple linear regression. Bars
indicate the 95% confidence intervals (CI) of the estimates. Independent variables shown in red have statistically significant coefficients (p < 0.05). (B) Plot showing
the predicted infarct growth values for recanalizers and non-recanalizers with good and poor Higashida scores. The plot shows that good collateral flow is associated
with less infarct growth, but there is no significant association between recanalization and infarct growth. In addition, the association between collateral flow and infarct
growth is similar across patients, whether or not they recanalized.
agreement with studies using CTA (30), DSC-derived cerebral
blood volume (31), the Higashida score (32) and DSA (33,
34). However, unlike previous studies (33), we did not find
that patients with poor collaterals and recanalization had less
infarct growth than those with poor collaterals and persistent
vessel occlusion. Recanalization, on the other hand, was not
independently associated with infarct growth in our study,
unlike in previous studies (32, 33). A possible explanation for
this could be that recanalization was assessed relatively late in
our study—patients could have spontaneously recanalized any
time between the baseline and follow-up exams, a period of
up to 24 h. In late recanalizers, most of the infarct growth
could have already occurred by the time recanalization was
assessed in our study. This may also explain the discrepancy
between our results and those of previous studies where
recanalization was assessed immediately after endovascular
therapy (32, 33). In a similar study of 44 patients that assessed
recanalization >24 h after baseline MRI, it was also found that
recanalization was not independently associated with infarct
growth (34).
Our study showed that neither reperfusion nor collateral
flow at baseline was independently associated with long-term
clinical outcome. Studies on whether collateral flow predicts
clinical outcome in relation to recanalization have yielded
contradictory findings. In 60 patients, Marks et al. (33) found
no difference in clinical outcome between patients with poor
and good collateral flow (assessed using digital subtraction
angiography) who recanalized. On the other hand, in the largest
MR perfusion-based study to date using the Higashida score
(n = 134), Kim et al. found that both good collateral flow
and recanalization were independently associated with good
clinical outcome (15). In agreement with the results of Marks
et al. (33), we found that recanalization was independently
associated with good clinical outcomes, and this effect did not
significantly differ between patients with different collateral flow
grades (Figure 2B). The lack of association between collateral
flow and clinical outcome, which runs contrary to the findings
of Kim et al. (15), may be due to the differences in the studied
stroke population. Whereas, Kim et al. (15) exclusively studied
patients with proximal (M1/ICA) vessel occlusions eligible
for thrombectomy, our sample was more diverse. The utility
of the Higashida score of collateral flow in such a diverse
sample of stroke patients should be further investigated in
future studies.
Interestingly, several lines of evidence suggest that the
potential effect of collateral flow on clinical outcome may be
more complicated than previously thought. Firstly, collateral
flow is dynamic and changes over time. Yeo et al. (35) found
that an improvement in collateral grade over time assessed
using CTA in patients without recanalization was associated
with worse outcome and mortality. Such slower recruitment of
collaterals is mediated by metabolic factors and angiogenesis, as
compared to the rapid response due to drop in perfusion pressure
and relaxation of smooth muscles with a resulting pressure
gradient (36). The detrimental effect of this delayed response
might be due to maximal vasodilation of collaterals in the
ischemic area and a steal-like effect by recruitment of collaterals
in adjacent regions resulting in infarct progression. Another
explanation could be failed autoregulation in the affected area
with reperfusion injury. Campbell et al. (16) also pointed
out that fluctuations in collateral flow over time underscore
the problem of accurately predicting infarct growth based on
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perfusion lesions derived from single thresholds. Depending on
individual factors, these changes in collateral flow over time
determine which regions of hypoperfused tissue progress to
irreversible damage.
Another issue that complicates collateral flow assessment is
methodological. Perfusion measurements using either MRI or
CT cannot differentiate between rapid collaterals successfully
maintaining perfusion to preserve and save brain tissue
or collateral flow to increase regional cerebral perfusion
above normal, which might in turn be harmful (37). This
distinction is important, because the temporal behavior of
collateral filling seems to be relevant for infarct evolution.
Beyer et al. (38) demonstrated that faster collateral filling
(assessed using dynamic CTA reconstructed from whole-brain
CT perfusion raw data) was associated with smaller follow-
up infarct lesions, an effect which was independent of extent
of collateralization.
The limitations of our study include its single-center
observational nature and the fact that recanalization and
reperfusion were assessed 24 h following the initial MR
examination. It is also important to note that overall, our study
was powered to detect small-to-medium effect sizes (Cohen’s
f2 = 0.1) (31), and it is therefore possible that very small
effects could have been missed. This is particularly likely in
the analyses of long-term clinical outcome and infarct growth,
where incomplete patient data reduced the analyzed sample size
(to 149 and 141, respectively). On the other hand, our study
is one of the largest analyses thus far of the influence of MRI-
based imaging variables on clinical and imaging stroke outcomes.
Although the cohort we studied here is heterogeneous, it possibly
reflects better the kind of stroke population encountered in
clinical routine. Most previous MR-based studies (10, 15, 39–
41) have restricted the assessment of reperfusion, collateral
flow, and recanalization to patients with occlusions of proximal
vessels of the anterior circulation, as these have thus far
been the main target for mechanical thrombectomy. However,
endovascular therapy is increasingly being performed in more
distal vessel occlusions as well as posterior circulation occlusions,
and imaging-based biomarkers of outcome are also potentially
relevant for patients who do not undergo thrombectomy. It is
therefore important for such biomarkers to be investigated in
wider patient cohorts, and our study presents a first step in
doing so.
CONCLUSION
MR-based measures of collateral flow and vessel recanalization
are independently associated with reperfusion and infarct
growth. The association between good collateral flow and more
reperfusion or less infarct growth holds true regardless of
recanalization status. Clinical outcome, on the other hand, is
associated with baseline stroke severity and recanalization, but
not DSC-MRI-based collateral flow status in this cohort of stroke
patients with a range of vessel occlusion and stroke locations.
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